Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Lymphoid Reconstitution

Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma

Bone Marrow Transplantation volume 31, pages 1009–1013 (2003)Cite this article

Summary:

The importance of the association between early lymphocyte recovery and outcome has not been well studied in autologous stem cell transplantation (ASCT). In this retrospective study, we analyzed 90 consecutive patients with non-Hodgkin's and Hodgkin's lymphoma who underwent ASCT. Patients were divided into two groups: group 1 with absolute lymphocyte count (ALC) on day +15 below the median of 667/mm3, and group 2 with ALC ⩾667/mm3. The median progression-free survival (PFS), but not overall survival (OS), was significantly longer in group 2 when compared to group 1 (16 months vs not reached P=0.02). Group 2 patients also had significantly shorter hospital stay, received higher CD34+ cell dose, and had shorter time to neutrophil recovery. Multivariate analysis demonstrated day +15 ALC to be an independent prognostic indicator for PFS, but not OS, while CD34+ cell dose and the number of pretransplant treatments were better predictors for both PFS and OS. We conclude that higher day +15 ALC may independently predict better PFS after ASCT for lymphoma patients; however, whether this merely reflects faster overall recovery caused by higher infused CD34+ cell dose and less pretransplant therapy needs further investigation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Cabanillas F, Hagemeister FB, Bodey GP et al. IMVP16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 1982; 60: 693–697.

    CAS  PubMed  Google Scholar 

  2. Cabanillas F, Hagemeister FB, McLaughlin P et al. Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 1987; 3: 407–412.

    Article  Google Scholar 

  3. Velasquez WS, Cabanillas F, Salvadore P et al. Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara C and dexamethasone (DHAP). Blood 1988; 71: 117–122.

    CAS  PubMed  Google Scholar 

  4. Philip T, Armitage JO, Spitzer G et al. High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493–1498.

    Article  CAS  PubMed  Google Scholar 

  5. Philip T, Hartman O, Biron P et al. High dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma. J Clin Oncol 1988; 6: 1118–1124.

    Article  CAS  PubMed  Google Scholar 

  6. Philip T, Guglielmi C, Hagenbeek A et al. A prospective randomized study comparing autologous bone marrow transplantation (ABMT) and salvage chemotherapy (DHAP) in sensitive-relapse of non-Hodgkin's lymphoma (NHL): final analysis of the PARMA study. N Engl J Med 1991; 333: 1540–1545.

    Article  Google Scholar 

  7. Bosly A, Coiffier B, Gisselbrecht C et al. For the Groupe d'Etude des Lymphomes Agressifs. Bone marrow transplantation significantly prolongs survival after relapse in aggressive lymphoma patients treated with the LNH84 regimen. J Clin Oncol 1992; 10: 1615–1623.

    Article  CAS  PubMed  Google Scholar 

  8. Powles R, Singhai S, Treleaven J et al. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood 1998; 91: 3481–3486.

    CAS  PubMed  Google Scholar 

  9. Pavletic ZS, Joshi SS, Piruccello SJ et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematological malignancies. Bone Marrow Transplant 1998; 21: 33–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Porrata LF, Gertz MA, Inwards DJ et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma and non-Hodgkin lymphoma. Blood 2001; 98: 579–585.

    Article  CAS  PubMed  Google Scholar 

  11. Sugrue MW, Williams K, Pollock BH et al. Characterization and outcome of ‘hard to mobilize’ lymphoma patients undergoing autologous stem cell transplantation. Leukemia Lymphoma 2000; 39: 509–519.

    Article  CAS  PubMed  Google Scholar 

  12. Barrett AJ, Ringden O, Zhang MJ et al. Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood 2000; 95: 3323–3327.

    CAS  PubMed  Google Scholar 

  13. Guillaume T, Rubinstein DB, Symann M et al. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471–1990.

    CAS  PubMed  Google Scholar 

  14. Storek J, Ferrara S, Ku N et al. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387–398.

    CAS  PubMed  Google Scholar 

  15. Bengtsson M, Smedmyr B, Festin R et al. B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: Increased numbers of B cells carrying activation and progression markers. Leukemia Res 1989; 13: 791–797.

    Article  CAS  Google Scholar 

  16. Small TN, Keever CA, Weiner-Fedus S et al. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76: 1647–1656.

    CAS  PubMed  Google Scholar 

  17. Leitenberg D, Rappeport JN, Smith BR . B-cell precursor bone marrow reconstitution after bone marrow transplantation. Am J Clin Pathol 1994; 102: 231–236.

    Article  CAS  PubMed  Google Scholar 

  18. Bengtsson M, Totterman TH, Smedmyr B et al. Regeneration of functional and activated NK and T subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3 color FACS analysis. Leukemia 1989; 3: 68–75.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology-Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA

    L N Gordan, J W Lynch, S A Khan & J S Moreb

  2. Shands Hospital, Gainesville, FL, USA

    M W Sugrue & K D Williams

Authors
  1. L N Gordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M W Sugrue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J W Lynch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K D Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S A Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J S Moreb
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordan, L., Sugrue, M., Lynch, J. et al. Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma. Bone Marrow Transplant 31, 1009–1013 (2003). https://doi.org/10.1038/sj.bmt.1704050

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704050

Keywords

This article is cited by

Search

Advanced search

Quick links